Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01951079

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01951079
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01951079. Allocation not applicable; no masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy
Condition
Arrhythmia
Condition
ECG Changes
Condition
Hypotension
Intervention (Drug)
Intra-amniotic injection of DIGOXIN
Lead sponsor
Meir Medical Center (class: other)

Record details

Record id
cardio:ct-nct01951079
Content hash
a6802227ca2cc61af278a888afaaefa2f3bb6813b9d2a9e6ad81eb452a418cbf